May 23, 2018 / 12:32 PM / in a month

BRIEF-Teva Confirms September PDUFA Date For Fremanezumab

May 23 (Reuters) - Teva Pharmaceutical Industries Ltd :

* TEVA CONFIRMS SEPTEMBER PDUFA DATE FOR FREMANEZUMAB

* TEVA PHARMACEUTICAL INDUSTRIES LTD - PRESCRIPTION DRUG USER FEE ACT (PDUFA) ACTION DATE FOR FREMANEZUMAB IS SET FOR SEPTEMBER 16

* TEVA PHARMACEUTICAL INDUSTRIES - CONFIRMED THAT FDA EXTENDED GOAL DATE OF BLA FOR FREMANEZUMAB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below